Severe Kawasaki Disease and Thrombocytopenia: A Case Report

Ghizlane Souni1,2, Ghanam Ayad1,2, Aziza Elouali1,2

  • 1Pediatrics, Mohammed VI University Hospital, Oujda, MAR.

Cureus
|September 4, 2023
PubMed

Insights

Kawasaki disease, a vasculitis affecting coronary arteries, typically presents with thrombocytosis. This case highlights a rare presentation of Kawasaki disease with thrombocytopenia, successfully treated with immunoglobulins and aspirin.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Immunology

Background:

  • Kawasaki disease (KD) is a medium vessel vasculitis primarily impacting coronary arteries.
  • Diagnosis relies heavily on clinical criteria, with thrombocytosis being a common laboratory finding.
  • The underlying mechanism of KD remains largely unknown.

Observation:

  • A 2-year-old girl presented with a week-long fever and rash.
  • Clinical signs included a generalized rash, conjunctivitis, cheilitis, and strawberry tongue.
  • Initial laboratory tests revealed an inflammatory syndrome and significant thrombocytopenia (91,000/mm³).

Findings:

  • This case presents an atypical biological profile for Kawasaki disease, characterized by thrombocytopenia instead of the usual thrombocytosis.
  • The patient received standard treatment with intravenous immunoglobulins and acetylsalicylic acid.
  • The treatment resulted in a favorable clinical evolution and complete resolution of thrombocytopenia.

Implications:

  • This case underscores the importance of considering Kawasaki disease even with atypical laboratory findings like thrombocytopenia.
  • Early diagnosis and treatment are crucial for preventing coronary artery complications.
  • Further research may elucidate the varied pathophysiological mechanisms underlying Kawasaki disease presentations.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
989
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
14
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
560
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10